Epidiolex-induced skin rash.
Epileptic Disord. 2020 Jul 30;:
Authors: Singh J, Antimisiaris MF
Epidiolex® (cannabidiol, aka CBD) is a recently approved FDA prescription drug for the treatment of epilepsy associated with Lennox-Gastaut and Dravet syndromes, and is increasingly used for treatment-resistant epilepsy. Rash was rarely reported in Epidiolex® clinical trial data. We report a case of Epidiolex®-related skin rash that developed in a delayed fashion in a 23-year-old female with medically refractory epilepsy. We also review the potential mechanism of Epidiolex®-related skin rash.
PMID: 32729550 [PubMed – as supplied by publisher]